NKX3-1 and benign prostatic hyperplasia: We tested and confirmed a significant increase in expression of HOXB13, AR, ORM1, KLK3, and NKX3-1 in PCa compared to symptomatic BPH in our validation studies with tissue specimens and cell line models.